Nascimbeni Riccardo, Nivatvongs Santhat, Larson Dirk R, Burgart Lawrence J
Department of Surgery, University of Brescia, Brescia, Italy.
Dis Colon Rectum. 2004 Nov;47(11):1773-9. doi: 10.1007/s10350-004-0706-9.
Many authors have reported high rates of local recurrence after local excision for early carcinoma of the rectum, which raises the question of whether oncologic resection gives better results. This study was designed to compare the long-term recurrence rate, long-term survival, and risk factors for T1 adenocarcinoma of the rectum treated with local excision or oncologic resection.
We identified 144 patients who had T1 sessile adenocarcinoma in the lower third or middle third of the rectum. Patients who received adjuvant therapy or who had pedunculated lesions were excluded. Data included age, gender, size of lesion, histologic type of carcinoma, grade, presence of lymphovascular invasion, and depth of invasion. Outcomes were defined as five-year and ten-year cumulative probabilities of local recurrence, distant metastasis, overall survival, and cancer-free survival. The mean follow-up was 9.2 years; median follow-up was 8.1 years.
We compared 70 patients who underwent local excision with 74 patients who underwent oncologic resection. Among patients with lesions in the middle or lower third of the rectum, 1) the five-year and ten-year outcomes were significantly better for overall survival and cancer-free survival in the oncologic resection group, but there were no significant differences in local recurrence or distant metastasis; 2) the multivariate risk factors for long-term, cancer-free survival were invasion into the lower third of the submucosa, local excision, and older than aged 68 years; and 3) for lesions with invasion into the lower third of the submucosa, the oncologic resection group had lower rates of distant metastasis and better survival. Among patients with lesions in the lower third of the rectum, 1) the five-year and ten-year outcomes showed no significant differences in survival, local recurrence, or distant metastasis between the two groups; and 2) for lesions with invasion into the lower third of the submucosa, the oncologic resection group showed a trend of improved survival, which was not statistically significant, possibly because of low statistical power from the small sample size.
Patients who undergo local excision or oncologic resection for T1 carcinoma in the lower two-thirds of the rectum have a high incidence of local recurrence and distant metastasis. To improve the cure rate, the rate of recurrence must decrease. A randomized, controlled study is needed to determine whether adjuvant therapy may be beneficial.
许多作者报告了早期直肠癌局部切除术后局部复发率较高,这引发了肿瘤切除是否能取得更好效果的问题。本研究旨在比较局部切除或肿瘤切除治疗直肠T1腺癌的长期复发率、长期生存率及危险因素。
我们确定了144例直肠下三分之一或中三分之一处患有T1无蒂腺癌的患者。排除接受辅助治疗或有带蒂病变的患者。数据包括年龄、性别、病变大小、癌组织学类型、分级、淋巴管侵犯情况及浸润深度。结局定义为局部复发、远处转移、总生存及无癌生存的五年和十年累积概率。平均随访时间为9.2年;中位随访时间为8.1年。
我们将70例行局部切除的患者与74例行肿瘤切除的患者进行了比较。在直肠中三分之一或下三分之一处有病变的患者中,1)肿瘤切除组的总生存和无癌生存的五年及十年结局明显更好,但局部复发或远处转移无显著差异;2)长期无癌生存的多变量危险因素为浸润至黏膜下层下三分之一、局部切除及年龄大于68岁;3)对于浸润至黏膜下层下三分之一的病变,肿瘤切除组的远处转移率较低且生存率更好。在直肠下三分之一处有病变的患者中,1)两组在生存、局部复发或远处转移方面的五年和十年结局无显著差异;2)对于浸润至黏膜下层下三分之一的病变,肿瘤切除组有生存改善趋势,但无统计学意义,可能是由于样本量小导致统计效能低。
直肠下三分之二处T1癌行局部切除或肿瘤切除的患者局部复发和远处转移发生率较高。为提高治愈率,必须降低复发率。需要进行一项随机对照研究来确定辅助治疗是否有益。